The early findings of the coronavirus vaccine developed by CanSino Biologics have shown encouraging results, Chinese researchers said. The potential coronavirus vaccine looked safe and triggered an immune response in adults in the preliminary trials.
The phase 1 trials showed that the vaccine, Ad5-nCoV, has potential to train the human body to resist infection by the new SARS-CoV-2 virus, according to the study published in the health journal The Lancet. The phase 1 trials were conducted in Wuhan, Hubei province of China where the virus originated.
Union Health Minister Harsh Varshan on Sunday said that at least four of the candidate coronavirus vaccines are soon expected to enter the clinical trial stage.
“There are over 100 candidate vaccines which are at different levels of development. The World Health Organisation (WHO) is coordinating the efforts. India is also actively contributing in it,” Vardhan said in a social media interaction with Bharatiya Janata Party (BJP) leader G V L Narasimha Rao.
Meanwhile, India’s total number of coronavirus cases jumped to 139,237 and deaths to 4,024. Globally, 5,514,011 people have been infected by coronavirus so far, and the total number of deaths from the disease now stands at 346,877.
